
The Academic Directorate of Communicable Diseases and Specialised Medicine comprises of five specialities:
The Academic Directorate of Communicable Disease & Specialised Medicine Research Strategy 2018-2021 is available on request - sth.getinvolved@nhs.net
Key Contacts
Name
|
Role |
---|---|
Dr Andy Chantry | Research Lead - Haemotology |
Dr Karen Rogstad
|
Research Lead – Sexual Health and GUM
|
Eva Zincone - eva.zincone@nhs.net | Directorate Research Coordinator |
Dr Paul Collini | Research Lead - Infectious Diseases |
Prof Steve Green | Clinical Director |
Dr Ravishankar Sargur | Research Lead - Immunology |
Prof Mike Cork | Research Lead - Dermatology |
Aimee Card - aimee.card@nhs.net
|
CRIO Research Coordinator |
Communicable Diseases
The Communicable Diseases team focuses on the prevention and treatment of infectious diseases through behavioural modification, vaccination and preventive treatment. Since all sectors of society are at risk of infections these approaches impact the lives of all society. Moreover since many of the problems we tackle, such as HIV, hepatitis, influenza, enteric fever and pneumonia have global reach our research is relevant not just in the UK.
The Communicable Diseases research team at Sheffield Teaching Hospitals are involved in trials in the following areas:
- HIV
- TB
- Meningitis
- Sexually Transmitted Infections

Specialised Medicine
The diverse specialties encompassed in the specialised medicine team address some of the most common disorders presenting to healthcare professionals within the NHS, ranging from dermatological, immune and haematological disorders including cancer.
Haematology
-
AML
-
CLL
-
Lymphoma
-
Myeloma
-
Sickle Cell Disease
-
GVHD
.jpg)
- novel non-factor haemophilia treatment
- Gene therapy in haemophilia
- long-acting factor treatments
- joint disease in haemophilia
- genetics of rare bleeding conditions
For a list of the current studies within the Haemophilia and Thrombosis Centre at Sheffield Teaching Hospitals please click here.
-
A trial looking at the health status and quality of life of patients with congenital agammaglobulinaemia in the United Kingdom
-
The UK PID registry, details of which can be found here
-
A trial looking at the molecular genetics of adverse drug reactions
-
Psoriasis
-
Atopic dermatitis (Eczema)
-
Registry studies of patients receiving treatment for dermatological conditions
-
Alopecia